stockrowInsmed, Inc.
INSM Healthcare Biotechnology
Insmed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.4 million, up 66.7% from fiscal 2024.
- Revenue
- +268.4%
- EPS
- +73.8%
- Free cash flow
- +81.1%
- Total debt
- +0.27%
Quarter to September 2026, against a year earlier
Follow INSM
Alert me
Insmed, Inc. (INSM) Operating margin
Insmed, Inc.'s operating margin over the twelve months to 30 September 2026 was −37.1%, up 168.5 percentage points from fiscal 2025 (−205.6%). Over the past ten years it has ranged from −3,124.9% (fiscal 2018) to 0.00% (fiscal 2017); the current reading is higher than 36% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −205.6% | 35.88 |
| FY2024 | −241.5% | (8.96) |
| FY2023 | −232.5% | (46.12) |
| FY2022 | −186.4% | 12.64 |
| FY2021 | −199.0% | (37.71) |
| FY2020 | −161.3% | 11.06 |
| FY2019 | −172.4% | 2,952.56 |
| FY2018 | −3,124.9% | (3,124.94) |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | 0.00 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −17.0% | (16.68) |
| Jun 2026 | −0.36% | 49.75 |
| Mar 2026 | −50.1% | 71.08 |
| Dec 2025 | −121.2% | 135.94 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| EXEL Exelixis, Inc. compare | 40.2% |
| GMAB Genmab A/S Sponsored ADR compare | 26.0% |
| ASND Ascendis Pharma A/S compare | 24.8% |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 19.5% |
| INCY Incyte Corporation compare | 10.4% |
| INSM Insmed, Inc. | −37.1% |
| BBIO BridgeBio Pharma, Inc. compare | −38.5% |
| BNTX BioNTech SE Sponsored ADR compare | −79.0% |
| ROIV Roivant Sciences Ltd. compare | −7,914.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on INSM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement